ArticleMaterials today. Bio2025
Superhydrophobic ROS biocatalytic metal coatings for the rapid healing of diabetic wounds.
Article in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Intelligent Biosensors for Diabetic Wound Monitoring.Biosensors · 2026Review
- NbAdvanced healthcare materials · 2026Article
- Atomically preserved MXene quantum dots as a redox-responsive nanoplatform for light-controlled bidirectional ROS engineering.Materials today. Bio · 2026Article
- Curcumin-loaded copper/iron bimetallic nanoparticle-incorporated hydrogel scaffold: a sequential microenvironment reprogramming platform for accelerated chronic wound healing.Journal of nanobiotechnology · 2026Article
- Stimuli-responsive hydrogels based on cascade reactions: a novel strategy to promote the efficient repair of diabetic wounds.Theranostics · 2026Review
- Review
- Regulatory T Cells in Diabetic Wound Healing: A Comprehensive Review.Journal of inflammation research · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In diabetic patients, hyperglycemia-induced elevated reactive oxygen species (ROS) accumulation severely impairs chronic wound healing by causing cellular component oxidation, inducing DNA damage, triggering cell death, exacerbating inflammatory responses, disrupting vascular endothelial function, reducing local blood supply, and inhibiting angiogenesis. This cascade results in a vicious cycle that delays the healing process. In this study, we developed a novel multifunctional composite dressing by depositing a transition-metal catalytic coating onto a superhydrophobic polydimethylsiloxane layer via magnetron sputtering. Two coatings were developed based on vanadium-ruthenium-boron (VRuB) intermetallic and VRu intermetallic compounds, which functioned as intermetallic compounds and exhibited various enzyme-like activities. The VRuB coating exhibited particularly prominent catalase-like activity (maximal reaction velocity (V
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.